Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of AMW Goserelin vs AMW Leuprorelin implants in prostate cancer
2009-015881-71Phase 3Completed
- Sponsor
- AMW GmbH
- Start
- Nov 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of goserelin and leuprolide in prostate cancer (PCa) (2 arms), sponsored by AMW GmbH. Primary endpoint: Testosterone suppression below castrate level. Started Nov 2009; status: completed.
02
Drugs
goserelinleuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2009-015881-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015881-71.